CR
Claude Ranoux
10% Owner

Claude Ranoux insider trades: INVO Bioscience (IVOB) stock sales

10% Owner, INVO Bioscience Last trade Dec 3, 2018 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
24
Open-market trades
since 2017
1
Company
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Claude reports to the SEC

Open-market buys and sales

24 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 3, 2018IVOB↓ Sell$25K
Mar 5, 2018IVOB↓ Sell$3K
Feb 28, 2018IVOB↓ Sell$360
Feb 23, 2018IVOB↓ Sell$18
Feb 21, 2018IVOB↓ Sell$14K
Feb 16, 2018IVOB↓ Sell$2K
Feb 13, 2018IVOB↓ Sell$1K
Feb 7, 2018IVOB↓ Sell$2K
Feb 2, 2018IVOB↓ Sell$2K
Jan 29, 2018IVOB↓ Sell$4K
Jan 25, 2018IVOB↓ Sell$250
Jan 22, 2018IVOB↓ Sell$5K
Jan 16, 2018IVOB↓ Sell$87
Jan 12, 2018IVOB↓ Sell$2K
Jan 8, 2018IVOB↓ Sell$13K
Jan 5, 2018IVOB↓ Sell$25K
Jan 4, 2018IVOB↓ Sell$420
Dec 29, 2017IVOB↓ Sell$701
Dec 27, 2017IVOB↓ Sell$2K
Dec 20, 2017IVOB↓ Sell$2K
Dec 18, 2017IVOB↓ Sell$5K
Dec 11, 2017IVOB↓ Sell$9K
Aug 8, 2017IVOB↓ Sell$22K
Jun 19, 2017IVOB↓ Sell$30K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Claude Ranoux's insider trades

Claude Ranoux is a 10% owner of INVO Bioscience (IVOB). Since Jun 19, 2017, Claude has reported no open-market purchases and 24 sales worth $168K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IVOB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.